Susquehanna International Group
IOBT

Susquehanna International Group’s IO Biotech IOBT Stock Holding History

Susquehanna International Group’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-26,676
Closed -$141K – 13389
2022
Q1 		$141K Buy
+26,676
New +$176K ﹤0.01% 11613

Other funds holding IOBT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group's IOBT Position: Q2 2022 in Review

Susquehanna International Group sold out of IO Biotech (IOBT) in Q2 2022, closing a stake of 26,676 shares — an estimated $141K sold.

Susquehanna International Group first reported a position in IOBT in Q1 2022 and held it in 1 quarter. The position peaked at $141K in Q1 2022. 18 funds tracked by Wall St. Rank hold IOBT as of Q2 2022.

  • Susquehanna International Group reported no remaining IO Biotech position as of Q2 2022 after selling out during the quarter.
  • Susquehanna International Group sold 26,676 IO Biotech shares in Q2 2022, an estimated $141K.
  • Susquehanna International Group first reported a position in IO Biotech in Q1 2022 and held it in 1 quarter.
  • Susquehanna International Group's IO Biotech position peaked at $141K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held IO Biotech as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.